• Профілактика неонатальних інфекцій стрептококової групи В з раннім початком
ua До змісту

Профілактика неонатальних інфекцій стрептококової групи В з раннім початком

HEALTH OF WOMAN. 2017.8(124):116–123

Hughes RG, Brocklehurst P, Steer PJ, Heath P, Stenson BM on behalf of the Royal College of Obstetricians and Gynaecologists
Green-top Guideline No. 36. BJOG 2017; DOI: 10.1111/1471-0528.14821.
Скорочений варіант. Адаптовано – С.О. Шурпяк

Література:
1. Lancefield RC. The antigenic complex of streptococcus hжmolyticus: I. Demonstration of a type-specific substance in extracts of streptococcus hжmolyticus. J Exp Med 1928;47:91–103. https://doi.org/10.1084/jem.47.6.843; https://doi.org/10.1084/jem.47.3.481; https://doi.org/10.1084/jem.47.1.91; https://doi.org/10.1084/jem.47.6.857; PMid:19869404 PMCid:PMC2131344

2. Royal College of Obstetricians and Gynaecologists. Audit of Current Practice in Preventing Early-Onset Neonatal Group B Streptococcal Disease in the UK. First Report. RCOG: London; 2015.

3. O’Sullivan C, Lamagni T, Efstratiou A, Patel D, Cunney R, Meehan M, et al. P3 Group B Streptococcal (GBS) disease In UK and Irish infants younger than 90days, 2014–2015. Arch Dis Child 2016;101:A2. https://doi.org/10.1136/archdischild-2016-310863.3

4. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1–36. PMid:21088663

5. Lukacs SL, Schoendorf KC, Schuchat A. Trends in sepsis-related neonatal mortality in the United States, 1985–1998. Pediatr Infect Dis J 2004;23:599–603. https://doi.org/10.1097/01.inf.0000131633.74921.90; PMid:15247595

6. Schrag SJ, Farley MM, Petit S, Reingold A, Weston EJ, Pondo T, et al. Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014. Pediatrics 2016;138: https://www.ncbi.nlm.nih.gov/pubmed/27940705. https://doi.org/10.1542/peds.2016-2013; PMid:27940705

7. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2014;(6):CD007467. https://doi.org/10.1002/14651858.CD007467.pub4

8. Chaudhuri K, Gonzales J, Jesurun CA, Ambat MT, Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth 2008;17:350–7. https://doi.org/10.1016/j.ijoa.2008.05.002; PMid:18691872

9. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347:240–7. https://doi.org/10.1056/NEJMoa012657; PMid:12140299

10. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003;3:201–13. https://doi.org/10.1016/S1473-3099(03)00577-2

11. UK National Screening Committee. Group B Streptococcus: The UK NSC Policy on Group B Streptococcus Screening in Pregnancy. London: NSC; 2008 [www.screening.nhs.uk/groupbstreptococcus].

12. Heyderman RS, Madhi SA, French N, Cutland C, Ngwira B, Kayambo D, etal. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non- randomised phase 2, open-label, multicentre trial. Lancet Infect Dis 2016;16:546–55. https://doi.org/10.1016/S1473-3099(15)00484-3

13. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, et al. Factors influencing women’s attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey. BMJ Open 2016;6:e010790. https://doi.org/10.1136/bmjopen-2015-010790; PMid:27098824 PMCid:PMC4838698

14. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, et al. Attitudes towards vaccination against group B streptococcus in pregnancy. Arch Dis Child 2014;99:700–1. https://doi.org/10.1136/archdischild-2013-305716; PMid:24356806

15. Royal College of Obstetricians and Gynaecologists. Group B Streptococcus (GBS) Infection in Newborn Babies. Information for you. London: RCOG; 2017.

16. UK National Screening Committee. UK NSC Group B Streptococcus (GBS) Recommendation. London: UK NSC; 2017.

17. Turrentine MA, Colicchia LC, Hirsch E, Cheng PJ, Tam T, Ramsey PS, et al. Efficiency of screening for the recurrence of antenatal group B streptococcus colonization in a subsequent pregnancy: a systematic review and meta-analysis with independent patient data. Am J Perinatol 2016;33:510–17. PMid:26683604

18. Tam T, Bilinski E, Lombard E. Recolonization of group B Streptococcus (GBS) in women with prior GBS genital colonization in pregnancy. J Matern Fetal Neonatal Med 2012;25:1987–9. https://doi.org/10.3109/14767058.2012.670331; PMid:22384795

19. Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequent pregnancies of group B Streptococcus-colonized versus noncolonized women. Am J Perinatol 2013;30:383–8. PMid:23023558

20. Colicchia LC, Lauderdale DS, Du H, Adams M, Hirsch E. Recurrence of group B streptococcus colonization in successive pregnancies. J Perinatol 2015;35:173–6. https://doi.org/10.1038/jp.2014.185; PMid:25321646

21. Turrentine MA, Ramirez MM. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstet Gynecol 2008;112:259–64. https://doi.org/10.1097/AOG.0b013e31817f5cb9; PMid:18669720

22. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811–5. https://doi.org/10.1016/0029-7844(96)00320-1

23. Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess 2007;11:1–226. https://doi.org/10.3310/hta11290; PMid:17651659

24. Carstensen H, Christensen KK, Grennert L, Persson K, Polberger S. Early-onset neonatal group B streptococcal septicaemia in siblings. J Infect 1988;17:201–4. https://doi.org/10.1016/S0163-4453(88)96426-2

25. Faxelius G, Bremme K, Kvist-Christensen K, Christensen P, Ringertz S. Neonatal septicemia due to group B streptococci— perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988;16:423–30. https://doi.org/10.1515/jpme.1988.16.5-6.423; PMid:3071602

26. Christensen KK, Dahlander K, Linden V, Svenningsen N, Christensen P. Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 1981;12:143–50. https://doi.org/10.1016/0028-2243(81)90069-1

27. Allen VM, Yudin MH, Bouchard C, Boucher M, Caddy S, Castillo E, et al.; Infectious Diseases Committee, Society of Obstetricians and Gynaecologists of Canada. Management of group B streptococcal bacteriuria in pregnancy. J Obstet Gynaecol Can 2012;34:482–6. https://doi.org/10.1016/S1701-2163(16)35246-X

28. Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 1979;135:1062–5. https://doi.org/10.1016/0002-9378(79)90737-3

29. Kabiri D, Hants Y, Yarkoni TR, Shaulof E, Friedman SE, Paltiel O, et al. Antepartum membrane stripping in GBS carriers, is it safe? (The STRIP-G Study). PLoS ONE 2015;10:e0145905. https://doi.org/10.1371/journal.pone.0145905; PMid:26719985 PMCid:PMC4697801

30. National Institute for Health and Clinical Excellence. Caesarean Section. NICE clinical guideline 132. London: NICE; 2011.

31. Ramus RM, McIntire DD, Wendel Jr GD. Antibiotic chemopro- phylaxis for group B strep is not necessary with elective cesarean section at term. Am J Obstet Gynecol 1999;180:S85.

32. Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et al. International multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. Premature Rupture of the Membranes. Am J Obstet Gynecol 1998;179:635–9. https://doi.org/10.1016/S0002-9378(98)70056-0

33. National Institute for Health and Clinical Excellence. Inducing labour. NICE clinical guideline 70. London: NICE; 2008.

34. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case–control study. BMJ 2002;325:308. https://doi.org/10.1136/bmj.325.7359.308; PMid:12169506 PMCid:PMC117770

35. Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IA, Watterberg K, et al.; Chorioamnionitis Workshop Participants. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol 2016;127:426–36. https://doi.org/10.1097/AOG.0000000000001246; PMid:26855098 PMCid:PMC4764452

36. Hospital Episode Statistics Analysis, Health and Social Care Information Centre. Hospital Episode Statistics: Admitted Patient Care 2012-13. Leeds: HES; 2013.

37. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15–20. https://doi.org/10.1056/NEJM200001063420103; PMid:10620644

38. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al.; Active Bacterial Care Surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056–65. https://doi.org/10.1001/jama.299.17.2056; PMid:18460666

39. O’Sullivan C, Heath PT, Lamagni T, Boyle M, Doherty L, Reynolds A, et al. Group B Streptococcal Disease in Infants <90 Days of Age. Unpublished 2015 [www.rcpch.ac.uk/bpsu/gbs].

40. Daniels JP, Gray J, Pattison HM, Gray R, Hills RK, Khan KS; GBS Collaborative Group. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG 2011;118:257–65. https://doi.org/10.1111/j.1471-0528.2010.02725.x; PMid:21040389

41. Zanetti-D€allenbach RA, Holzgreve W, Ho€sli I. Neonatal group B streptococcus colonization in water births. Int J Gynaecol Obstet 2007;98:54–5. https://doi.org/10.1016/j.ijgo.2007.03.029; PMid:17475265

42. Thoeni A, Zech N, Moroder L, Ploner F. Review of 1600 water births. Does water birth increase the risk of neonatal infection? J Matern Fetal Neonatal Med 2005;17:357–61. https://doi.org/10.1080/14767050500140388; PMid:16147851

43. Zanetti-D€allenbach R, Lapaire O, Maertens A, Holzgreve W, Ho€sli I. Water birth, more than a trendy alternative: a prospective, observational study. Arch Gynecol Obstet 2006;274:355–65. https://doi.org/10.1007/s00404-006-0208-1; PMid:16868755

44. Baecher L, Grobman W. Prenatal antibiotic treatment does not decrease group B streptococcus colonization at delivery. Int J Gynaecol Obstet 2008;101:125–8. https://doi.org/10.1016/j.ijgo.2007.10.012; PMid:18082163

45. Bland ML, Vermillion ST, Soper DE. Late third-trimester treatment of rectovaginal group B streptococci with benzathine penicillin G. Am J Obstet Gynecol 2000;183:372–6. https://doi.org/10.1067/mob.2000.107668; PMid:10942472

46. Weeks JW, Myers SR, Lasher L, Goldsmith J, Watkins C, Gall SA. Persistence of penicillin G benzathine in pregnant group B streptococcus carriers. Obstet Gynecol 1997;90:240–3. https://doi.org/10.1016/S0029-7844(97)00247-0

47. National Institute of Health Care and Excellence. Preterm Labour and Birth. NICE guideline 25. London: NICE; 2015.

48. Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS, et al.; PPROMT Collaboration. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet 2016;387:444–52. https://doi.org/10.1016/S0140-6736(15)00724-2

49. Tajik P, van der Ham DP, Zafarmand MH, Hof MH, Morris J, Franssen MT, et al. Using vaginal Group B Streptococcus colonisa- tion in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG 2014;121:1263–72; discussion 1273. https://doi.org/10.1111/1471-0528.12889; PMid:24862166

50. Public Health England. UK Standards for Microbiology Investiga- tions. Detection of Carriage of Group B Streptococci. London: PHE; 2015.

51. Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol 2008;112:265–70. https://doi.org/10.1097/AOG.0b013e31817d0246; PMid:18669721 PMCid:PMC3144749

52. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204–10. https://doi.org/10.1067/mob.2001.113875; PMid:11349189

53. de Cuito M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91:112–14. https://doi.org/10.1016/S0029-7844(97)00587-5

54. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 2013;121:570–7. https://doi.org/10.1097/AOG.0b013e318280d4f6; PMid:23635620

55. National Institute of Health Care and Excellence. Neonatal Infection (Early Onset): Antibiotics for Prevention and Treatment. NICE clinical guideline 149. London: NICE, 2012.

56. UK Obstetric Surveillance System. Anaphylaxis in Pregnancy. Oxford: UKOSS; 2015 [www.npeu.ox.ac.uk/ ukoss/current-surveilla nce/aip?highlight=YTo0OntpOjA7czo4OiJtYXRlcm5hbCI7a ToxO3M6OToiJ21hdGVyb mFsIjtpOjI7czoxMToiYW5hcGh5bGF4a XMiO2k6MztzOjIwOiJtYXRlcm5hbCBhbmFwaHlsYXhpcyI7fQ==].

57. Mazzola G, Murphy K, Ross RP, Di GD, Biavati B, Corvaglia LT, et al. Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS ONE 2016;11:e0157527. https://doi.org/10.1371/journal.pone.0157527; PMid:27332552 PMCid:PMC4917232

58. Cassidy-Bushrow AE, Sitarik A, Levin AM, Lynch SV, Havstad S, Ownby DR, et al. Maternal group B Streptococcus and the infant gut microbiota. J Dev Orig Health Dis 2016;7:45–53. https://doi.org/10.1017/S2040174415001361; PMid:26264560 PMCid:PMC4847528

59. Aloisio I, Quagliariello A, De Fanti S, Luiselli D, De Filippo C, Albanese D, et al. Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal microbiota using a sequencing approach targeted to multi hypervariable 16S rDNA regions. Appl Microbiol Biotechnol 2016; 100: 5537–46. https://doi.org/10.1007/s00253-016-7410-2; PMid:26971496

60. Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG 2016;123:983–93. https://doi.org/10.1111/1471-0528.13601; PMid:26412384

61. Corvaglia L, Tonti G, Martini S, Aceti A, Mazzola G, Aloisio I, et al. Influence of intrapartum antibiotic prophylaxis for group B streptococcus on gut microbiota in the first month of life. J Pediatr Gastroenterol Nutr 2016;62:304–8. https://doi.org/10.1097/MPG.0000000000000928; PMid:26237371

62. Rachid R, Chatila TA. The role of the gut microbiota in food allergy. Curr Opin Pediatr 2016;28:748–53. https://doi.org/10.1097/MOP.0000000000000427; PMid:27749359

63. Mueller NT, Mao G, Bennet WL, Hourigan SK, Dominguez-Bello MG, Appel LJ, et al. Does vaginal delivery mitigate or strengthen the intergenerational association of overweight and obesity? Findings from the Boston Birth Cohort. Int J Obes (Lond) 2017;41:497–501. https://doi.org/10.1038/ijo.2016.219; PMid:27899809

64. Paun A, Danska JS. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr Diabetes 2016;17: 469–77. https://doi.org/10.1111/pedi.12424; PMid:27484959

65. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet 2008;372:1310–8. https://doi.org/10.1016/S0140-6736(08)61203-9; https://doi.org/10.1016/S0140-6736(08)61202-7

66. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow- up of the ORACLE II trial. Lancet 2008;372:1319–27. https://doi.org/10.1016/S0140-6736(08)61203-9; https://doi.org/10.1016/S0140-6736(08)61202-7

67. Marlow N, Bower H, Jones D, Brocklehurst P, Kenyon S, Pike K, et al. The ORACLE Children Study: educational outcomes at 11 years of age following antenatal prescription of erythromycin or co-amoxiclav. Arch Dis Child Fetal Neonatal Ed 2017;102:F131–5. https://doi.org/10.1136/archdischild-2015-310144; PMid:27515985 PMCid:PMC5339554

68. Ohlsson A, Shah VS, Stade BC. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev 2014;(12): CD003520. https://doi.org/10.1002/14651858.CD003520.pub3

69. Escobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE, et al. Neonatal sepsis workups in infants >/=2000 grams at birth: A population-based study. Pediatrics 2000;106:256–63. https://doi.org/10.1542/peds.106.2.256; PMid:10920148

70. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al.; PHLS Group B Streptococcus Working Group. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292–4. https://doi.org/10.1016/S0140-6736(03)15389-5